Allogene Therapeutics (ALLO) null Earnings

4NovConfirmed
Feb 21
May 21
Aug 21
Nov 21
-0.57
-0.46
-0.36
-0.25

Details

Expected EPS
-0.56
Actual EPS
-0.57
Surprise EPS
-0.01
Surprise Percent
+1.79%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.57 per share for .

0 Comments

Share your thoughts